In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PUBLICATIONS - Report on Opportunities for Manufacturers of Medical Equipment and Supplies in Latin America:

This article was originally published in Clinica

Executive Summary

Espicom has published a market report on Opportunities for Manufacturers of Medical Equipment and Supplies in Latin America. It contains an extensive overview on the leading markets within the region including Argentina, Brazil, Chile, Mexico and Colombia. Each country report covers the market background; public and private healthcare development plans; regulatory details; the structure of health services; health expenditure; market access; hospital services; and details of potential contacts. For more information contact Espicom in the UK. Tel: +44 1243 533 322. Fax: +44 1243 533 418.

You may also be interested in...



EMA's Decision On Ranitidine Remaining Available Could Come At End Of April

Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.

Perrigo Has Approval For Copy Of OTC Voltaren Arthritis Relief Before GSK Launches The Brand

Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.

2020 US Beauty May Be Headed For Record Declines, But There Are COVID-19 Opportunities

Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.

Topics

UsernamePublicRestriction

Register

MT081602

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel